220 related articles for article (PubMed ID: 36349176)
1. Effect of pan-retinal laser photocoagulation on intravitreal vascular endothelial growth factor concentration in proliferative diabetic retinopathy.
Nišić F; Pidro A; Lepara O; Fajkić A; Mioković AP; Suljić E; Nišić A; Kovačević I
Rom J Ophthalmol; 2022; 66(3):265-270. PubMed ID: 36349176
[No Abstract] [Full Text] [Related]
2. Predictors of visual outcome after pars plana vitrectomy secondary to proliferative diabetic retinopathy.
Nisic F; Gadzo AP; Fajkic A; Nisic A; Miokovic AP; Damjanovic G; Begic E; Beslic N; Lepara O
Rom J Ophthalmol; 2023; 67(3):283-288. PubMed ID: 37876512
[No Abstract] [Full Text] [Related]
3. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
[TBL] [Abstract][Full Text] [Related]
4. Vitreous Fibronectin and Fibrinogen Expression Increased in Eyes With Proliferative Diabetic Retinopathy After Intravitreal Anti-VEGF Therapy.
Wei Q; Zhang T; Jiang R; Chang Q; Zhang Y; Huang X; Gao X; Jin H; Xu G
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5783-5791. PubMed ID: 29117316
[TBL] [Abstract][Full Text] [Related]
5. Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy.
Shimura M; Yasuda K; Nakazawa T; Abe T; Shiono T; Iida T; Sakamoto T; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1617-24. PubMed ID: 19639332
[TBL] [Abstract][Full Text] [Related]
6. Need for Vitreous Surgeries in Proliferative Diabetic Retinopathy in 10-Year Follow-Up: India Retinal Disease Study Group Report No. 2.
Khan R; Surya J; Rajalakshmi R; Rani PK; Anantharaman G; Gopalakrishnan M; Sen A; Desai A; Roy R; Natarajan S; Chen L; Chawla G; Behera UC; Gopal L; Muralidharan V; Sivaprasad S; Raman R
Ophthalmic Res; 2021; 64(3):432-439. PubMed ID: 33142294
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review and Meta-Analysis of Clinical Outcomes of Small Gauge Vitrectomy with or without Intravitreal Anti-Vascular Endothelial Growth Factor Agents Pretreatment for Proliferative Diabetic Retinopathy.
Pei M; Zhao X; Wan G
Ophthalmic Res; 2023; 66(1):777-790. PubMed ID: 36972566
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Pars Plana Vitrectomy with Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy Without Retinal Detachment: A Seven-Year Retrospective Study.
Patel V; Rohowetz LJ; Pakravan P; Kalavar M; Yannuzzi NA; Sridhar J
Clin Ophthalmol; 2023; 17():471-478. PubMed ID: 36755887
[TBL] [Abstract][Full Text] [Related]
9. Anti-Vascular Endothelial Growth Factor and Panretinal Photocoagulation Use after Protocol S for Proliferative Diabetic Retinopathy.
Azad AD; Chen EM; Hinkle J; Rayess N; Wu D; Eliott D; Mruthyunjaya P; Parikh R
Ophthalmol Retina; 2021 Feb; 5(2):151-159. PubMed ID: 32693033
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta-analysis.
Fallico M; Maugeri A; Lotery A; Longo A; Bonfiglio V; Russo A; Avitabile T; Pulvirenti A; Furino C; Cennamo G; Barchitta M; Agodi A; Reibaldi M
Acta Ophthalmol; 2021 Sep; 99(6):e795-e805. PubMed ID: 33326183
[TBL] [Abstract][Full Text] [Related]
11. Comparison of before versus after intravitreal bevacizumab injection, growth factor levels and fibrotic markers in vitreous samples from patients with proliferative diabetic retinopathy.
Ozer F; Tokuc EO; Albayrak MGB; Akpinar G; Kasap M; Karabas VL
Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):1899-1906. PubMed ID: 35028761
[TBL] [Abstract][Full Text] [Related]
12. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy.
Li B; Li MD; Ye JJ; Chen Z; Guo ZJ; Di Y
Chin Med J (Engl); 2020 Mar; 133(6):664-669. PubMed ID: 32068603
[TBL] [Abstract][Full Text] [Related]
14. Ocular findings at initial pan retinal photocoagulation for proliferative diabetic retinopathy predict the need for future pars plana vitrectomy.
Parikh R; Shah RJ; VanHouten JP; Cherney EF
Retina; 2014 Oct; 34(10):1997-2002. PubMed ID: 24936944
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.
Obeid A; Su D; Patel SN; Uhr JH; Borkar D; Gao X; Fineman MS; Regillo CD; Maguire JI; Garg SJ; Hsu J
Ophthalmology; 2019 Mar; 126(3):407-413. PubMed ID: 30077614
[TBL] [Abstract][Full Text] [Related]
16. Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema.
Praidou A; Papakonstantinou E; Androudi S; Georgiadis N; Karakiulakis G; Dimitrakos S
Acta Ophthalmol; 2011 May; 89(3):248-54. PubMed ID: 19799585
[TBL] [Abstract][Full Text] [Related]
17. Vitreous Levels of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Patients with Proliferative Diabetic Retinopathy: A Clinical Correlation.
Al-Dwairi R; El-Elimat T; Aleshawi A; Al Sharie AH; Abu Mousa BM; Al Beiruti S; Alkazaleh A; Mohidat H
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002312
[No Abstract] [Full Text] [Related]
18. Vitreous levels of vascular endothelial growth factor, stromal cell-derived factor-1α, and angiopoietin-like protein 2 in patients with active proliferative diabetic retinopathy.
Keles A; Sonmez K; Erol YO; Ayyıldız SN; Ogus E
Graefes Arch Clin Exp Ophthalmol; 2021 Jan; 259(1):53-60. PubMed ID: 32813109
[TBL] [Abstract][Full Text] [Related]
19. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR PROLIFERATIVE DIABETIC RETINOPATHY: A Systematic Review and Meta-Analysis.
Simunovic MP; Maberley DA
Retina; 2015 Oct; 35(10):1931-42. PubMed ID: 26398553
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic shift in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
Yoshida S; Nakama T; Ishikawa K; Arima M; Tachibana T; Nakao S; Sassa Y; Yasuda M; Enaida H; Oshima Y; Kono T; Ishibashi T
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6997-7003. PubMed ID: 22977138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
